Barclays PLC raised its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 9.8% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 182,200 shares of the company’s stock after acquiring an additional 16,217 shares during the period. Barclays PLC owned approximately 0.15% of Clorox worth $28,831,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Dark Forest Capital Management LP acquired a new position in shares of Clorox during the 4th quarter worth about $28,000. OLD Mission Capital LLC bought a new position in Clorox in the 4th quarter valued at about $29,000. Delta Asset Management LLC TN bought a new position in shares of Clorox during the fourth quarter worth approximately $31,000. Janiczek Wealth Management LLC increased its holdings in shares of Clorox by 1,133.3% during the first quarter. Janiczek Wealth Management LLC now owns 222 shares of the company’s stock worth $35,000 after purchasing an additional 204 shares during the period. Finally, Financial Avengers Inc. increased its stake in Clorox by 86.0% in the fourth quarter. Financial Avengers Inc. now owns 225 shares of the company’s stock valued at $32,000 after acquiring an additional 104 shares during the last quarter. Institutional investors own 79.37% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have recently commented on the stock. Wells Fargo & Company lifted their price target on shares of Clorox from $145.00 to $150.00 in a report on Wednesday, May 3rd. Barclays raised their price objective on shares of Clorox from $117.00 to $127.00 and gave the company an “underweight” rating in a research report on Friday. UBS Group raised their price objective on shares of Clorox from $148.00 to $162.00 in a research report on Wednesday, May 3rd. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Clorox from $147.00 to $149.00 in a research report on Tuesday, April 18th. Finally, Bank of America raised their price target on shares of Clorox from $130.00 to $140.00 in a report on Wednesday, May 3rd. Seven analysts have rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $148.77.
Clorox Trading Down 1.3 %
Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Wednesday, August 2nd. The company reported $1.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.48. Clorox had a net margin of 2.02% and a return on equity of 163.73%. The business had revenue of $2.02 billion during the quarter, compared to analysts’ expectations of $1.88 billion. During the same period in the previous year, the company earned $0.93 earnings per share. The business’s revenue for the quarter was up 12.1% compared to the same quarter last year. As a group, analysts forecast that The Clorox Company will post 5.64 EPS for the current fiscal year.
Clorox Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 25th. Shareholders of record on Wednesday, August 9th will be issued a dividend of $1.20 per share. This is a boost from Clorox’s previous quarterly dividend of $1.18. This represents a $4.80 dividend on an annualized basis and a yield of 2.93%. The ex-dividend date of this dividend is Tuesday, August 8th. Clorox’s dividend payout ratio is currently 396.64%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- How to Invest in Blockchain Stocks Step by Step
- 3 Best Meme ETFs to Buy Now
- Investing in Vaccines 101: How to Invest in Vaccine Stocks
- XPO Keeps Reaching New Highs: Markets Love the Stock
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Starbucks Market at a Turning Point: Is a Breakout Imminent?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
